Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria.
We are looking for subjects who are affected by uncontrolled hypertension to participate in a research study to investigate a new experimental treatment.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.
The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
Learn more about a clinical trial of a study drug for people who are living with HFrEF. Also called systolic heart failure, HFrEF is a type of cardiac dysfunction where the heart is too weak to pump enough blood around the body.
Learn more about Pfizer’s research study for an investigational COVID-19 and flu combination vaccine.
TRIUMPH-3 is a clinical research study for people with excess weight and heart disease. The study will test how safe and well the investigational medicine (the medicine being studied) works for weight management.
If so, perhaps you can join the TRITON Study and possibly help find better treatment options for future sufferers of COPD.
Study participation is at no charge, and compensation for time and travel expenses may be available to those who satisfy applicable requirements.
To join the TRITON Study, potential participants must:
- Be a current or ex-smoker at least 40 years of age
- Have been diagnosed with COPD for at least one year
- Require daily medication to control their COPD symptoms
Other requirements may apply.
To learn more about the TRITON Study, a medical research study of an investigational medication for those who suffer from COPD, please contact us today 786-772-0510
This study is intended to assess the effectiveness of AXS-05 compared to bupropion in preventing relapse of depressive symptoms in people who have responded to treatment with AXS-05. AXS-05 is not approved for the prevention of relapse and its use in this study is investigational
This is a clinical research study to test the safety and effectiveness of an investigational medication for uncontrolled and resistant high blood pressure.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)